Tag: Pharmacogenetics Testing in PsychiatryDepression Market
Pharmacogenetics Testing in Psychiatry Market Enhances Personalized Mental Health Treatments
The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period
0
0
0
28 May, 10:54 AM
